HMGB1 and gastric cancer: In the paper by Hye-Won Chung [3], recipient of the "Excellence in Translational Medicine Award for 2008-09," Doctor Chung and colleagues of Yonsei University College of Medicine (Seoul, Korea) and the NIH (Bethesda, MD) have demonstrated a correlation between the serum levels of high mobility group protein box-1 (HMGB1) and the clinical and pathological characteristics of patients with gastric cancer (GC) and its suggested role therein as a biomarker.